Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial
- Resource Type
- Article
- Authors
- Le Gouill, Steven ; Morschhauser, Franck; Chiron, David; Bouabdallah, Krimo; Cartron, Guillaume; Casasnovas, Olivier; Bodet-Milin, Caroline; Ragot, Sylviane; Bossard, Céline; Nadal, Nathalie; Herbaux, Charles; Tessoulin, Benoit; Tchernonog, Emmanuelle; Rossi, Cédric; McCulloch, Rory; Gastinne, Thomas; Callanan, Mary B. ; Rule, Simon
- Source
- In Blood 18 February 2021 137(7):877-887
- Subject
- Language
- ISSN
- 0006-4971